Mamas A Mamas1, Simon G Anderson2, Karim Ratib3, Helen Routledge4, Ludwig Neyses5, Douglas G Fraser6, Iain Buchan7, Mark A de Belder8, Peter Ludman9, Jim Nolan3. 1. Manchester Heart Centre, Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom; Institute of Cardiovascular Sciences, University of Manchester, Oxford Road, Manchester, United Kingdom. Electronic address: mamasmamas1@yahoo.co.uk. 2. Manchester Heart Centre, Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom; Institute of Cardiovascular Sciences, University of Manchester, Oxford Road, Manchester, United Kingdom. 3. University Hospital of North Staffordshire, Stoke-on-Trent, United Kingdom. 4. Worcestershire Royal Hospital, Worcester, United Kingdom. 5. Institute of Cardiovascular Sciences, University of Manchester, Oxford Road, Manchester, United Kingdom. 6. Manchester Heart Centre, Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom. 7. Institute of Population Health Science, University of Manchester, Manchester, United Kingdom. 8. The James Cook University Hospital, Marton Road, Middlesbrough, United Kingdom. 9. Queen Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom.
Abstract
BACKGROUND: Cardiogenic shock (CS) remains the leading cause of mortality in patients hospitalized with acute myocardial infarction (AMI). The transradial access site (TRA) has become increasingly adopted as a default access site for percutaneous coronary intervention (PCI); however, even in experienced centers that favor the radial artery as the primary access site during PCI, patients presenting in CS are often treated via the transfemoral access site (TFA); and commentators have suggested that CS remains the final frontier that has given even experienced radial operators pause. We studied the use of TRA in patients presenting in CS in a nonselected high-risk cohort from the British Cardiovascular Intervention database over a 7-year period (2006-2012). METHODS: Mortality (30-day) and major adverse cardiac and cerebrovascular events (a composite of in-hospital mortality, in-hospital myocardial reinfarction, target vessel revascularization, and cerebrovascular events) were studied based on TFA and TRA utilization in CS patients. The influence of access site selection was studied in 7,231 CS patients; TFA was used in 5,354 and TRA in 1,877 patients. RESULTS: Transradial access site was independently associated with a lower 30-day mortality (hazard ratio [HR] 0.56, 95% CI 0.46-0.69, P = 0 < .001), in-hospital major adverse cardiac and cerebrovascular events (HR 0.64, 95% CI 0.53-0.76, P < .0001) and major bleeding (HR 0.37, 95% CI 0.18-0.73, P = .004). CONCLUSIONS: Although the majority of PCI cases performed in patients with cardiogenic shock in the United Kingdom are performed through the TFA, the radial artery represents an alternative viable access site in this high-risk cohort of patients in experienced centers.
BACKGROUND: Cardiogenic shock (CS) remains the leading cause of mortality in patients hospitalized with acute myocardial infarction (AMI). The transradial access site (TRA) has become increasingly adopted as a default access site for percutaneous coronary intervention (PCI); however, even in experienced centers that favor the radial artery as the primary access site during PCI, patients presenting in CS are often treated via the transfemoral access site (TFA); and commentators have suggested that CS remains the final frontier that has given even experienced radial operators pause. We studied the use of TRA in patients presenting in CS in a nonselected high-risk cohort from the British Cardiovascular Intervention database over a 7-year period (2006-2012). METHODS: Mortality (30-day) and major adverse cardiac and cerebrovascular events (a composite of in-hospital mortality, in-hospital myocardial reinfarction, target vessel revascularization, and cerebrovascular events) were studied based on TFA and TRA utilization in CS patients. The influence of access site selection was studied in 7,231 CS patients; TFA was used in 5,354 and TRA in 1,877 patients. RESULTS: Transradial access site was independently associated with a lower 30-day mortality (hazard ratio [HR] 0.56, 95% CI 0.46-0.69, P = 0 < .001), in-hospital major adverse cardiac and cerebrovascular events (HR 0.64, 95% CI 0.53-0.76, P < .0001) and major bleeding (HR 0.37, 95% CI 0.18-0.73, P = .004). CONCLUSIONS: Although the majority of PCI cases performed in patients with cardiogenic shock in the United Kingdom are performed through the TFA, the radial artery represents an alternative viable access site in this high-risk cohort of patients in experienced centers.
Authors: Ahmad H S Mustafa; Eric Holroyd; Rob Butler; Doug Fraser; Magdi El-Omar; James Nolan; Mamas A Mamas Journal: Curr Cardiol Rep Date: 2015-05 Impact factor: 2.931
Authors: Seref Ulucan; Zeynettin Kaya; Ahmet Keser; Hüseyin Katlandur; Hüseyin Özdil; İsmail Ateş; Mehmet S Ulgen Journal: Int J Clin Exp Med Date: 2015-07-15
Authors: Muhammad Junaid Ahsan; Soban Ahmad; Azka Latif; Noman Lateef; Mohammad Zoraiz Ahsan; Waiel Abusnina; Sandeep Nathan; S Elissa Altin; Dhaval S Kolte; John C Messenger; Mark Tannenbaum; Andrew M Goldsweig Journal: Eur Heart J Qual Care Clin Outcomes Date: 2022-09-05
Authors: Matthias Hasun; Jakob Dörler; Hannes F Alber; Axel Bauer; Rudolf Berger; Günter Christ; Matthias Frick; Uta C Hoppe; Kurt Huber; Gudrun Lamm; Elisabeth Laßnig; Dirk von Lewinski; Anna Rab; Franz X Roithinger; Herwig Schuchlenz; Peter Siostrzonek; Johann Sipötz; Thomas Stefenelli; Clemens Steinwender; Michael Edlinger; Franz Weidinger Journal: Cardiovasc Diagn Ther Date: 2021-06
Authors: Behnam N Tehrani; Abdulla A Damluji; Matthew W Sherwood; Carolyn Rosner; Alexander G Truesdell; Kelly C Epps; Edward Howard; Scott D Barnett; Anika Raja; Christopher R deFilippi; Charles E Murphy; Christopher M O'Connor; Wayne B Batchelor Journal: Catheter Cardiovasc Interv Date: 2020-08-03 Impact factor: 2.585